<DOC>
	<DOCNO>NCT00297011</DOCNO>
	<brief_summary>A randomize study compare combination valacyclovir temovate gel ( clobetasol gel ) versus placebo treatment recurrent herpes labialis ( cold sore ) .</brief_summary>
	<brief_title>Valacyclovir+Temovate Gel Treatment Herpes Labialis</brief_title>
	<detailed_description>Herpes simplex labialis common , worldwide affliction neither public health procedure , vaccine , antiviral chemotherapy major impact . The present study propose become clear marked limitation benefit antiviral therapy herpes labialis . Recently , pilot trial combination famciclovir topical 0.05 % fluocinonide v famciclovir alone show addition corticosteroid antiviral drug treatment cause mark statistically significant reduction lesion size trend abort lesion . This study design randomize , placebo-controlled , , patient-initiated study . The objective study evaluate safety efficacy oral valacyclovir 2grams BID one day topical temovate 0.05 % gel BID three day compare placebo capsule placebo gel episodic treatment single episode recurrent herpes labialis immunologically normal patient . Subjects screen , randomize study drug instruct start use study drug within one hour first sign symptom next episode herpes labialis . Data treat lesion collect clinic visit patient diary card .</detailed_description>
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Age 18 year old . A history typical recurrent herpes labialis . The subject must experience three cold sore last 12 month . In general good health , without serious medical condition , determine patient 's account his/her medical history . Signature informed consent document . Patients participate investigational drug study fourweek period prior enrollment . Previous herpes vaccine time . Patients major medical condition chronic heart , pulmonary , renal hepatic disease . Patients immunodeficiency disorder HIV infection cancer chemotherapy . Patients use topical steroid near face systemic steroid within 30 day enrollment . Women pregnant , lactate breast feeding . Women childbearing potential use adequate contraception judge Investigator . Recent history alcohol drug abuse , opinion investigator , may interfere study patient 's compliance study requirement . Significant skin disease atopic dermatitis , acne , rosacea would interfere assessment lesion . Allergy hypersensitivity steroid , acyclovir , penciclovir and/or nucleoside analogue . Subjects impaired renal function define serum creatinine upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>